You are now leaving Medical information including licensed uses may be different outside of the EU countries.

Kedrion Portugal is a biopharmaceutical company specializing in marketing, sales and distribution of plasma derivatives in Portugal.  Kedrion Portugal was founded in 2010 and is based in Lisbon, Portugal, where we service the hospital pharmaceutical market of Portugal.  We are a wholly-owned subsidiary of Kedrion International GmbH, based in Vienna, Austria.  In turn, Kedrion International GmbH is a wholly owned subsidiary of Kedrion S.p.A., based in Castelvecchio, Italy. Kedrion Portugal distributes Kedrion products exclusively in Portugal.

Kedrion Portugal provides plasma-derived therapies for:

  • Immune system diseases
  • Illnesses and conditions that require critical care, and
  • Bleeding disorders.



     Human Normal Immunoglobulins  
     lg Vena

     Human Hyperimmune Immunoglobulins
     Uman Big  

Human Albumin Solutions
      Albumina Humana Kedrion

Coagulation Factors
      Emoclot D.I.

These high-safety therapies are produced by Kedrion S.p.A. from human plasma collected only in Europe and the USA.


Kedrion Portugal
Av. José Gomes Ferreira, 15 – 5ºQ
Miraflores 1495-139 Algés

Ms. Joana Silvério Marques
Technical Director

Tel. +351 214 107 246
Fax. +351 214 100 645